IRIS
CUDILLO, LAURA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 22.995
EU - Europa 2.068
AS - Asia 626
SA - Sud America 14
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 2
Totale 25.711
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 22.984
DE - Germania 623
UA - Ucraina 343
CN - Cina 330
IT - Italia 266
IE - Irlanda 227
GB - Regno Unito 138
KR - Corea 130
SE - Svezia 114
RU - Federazione Russa 99
SG - Singapore 99
FR - Francia 89
FI - Finlandia 72
PL - Polonia 44
CZ - Repubblica Ceca 16
BE - Belgio 15
UZ - Uzbekistan 14
HK - Hong Kong 11
KG - Kirghizistan 10
CA - Canada 7
IN - India 7
JP - Giappone 7
AT - Austria 5
BR - Brasile 5
IR - Iran 5
CL - Cile 4
ES - Italia 4
EU - Europa 4
CH - Svizzera 3
GR - Grecia 3
MX - Messico 3
PE - Perù 3
RO - Romania 3
VN - Vietnam 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AU - Australia 2
IL - Israele 2
SA - Arabia Saudita 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AR - Argentina 1
BG - Bulgaria 1
DK - Danimarca 1
DM - Dominica 1
EC - Ecuador 1
EE - Estonia 1
KW - Kuwait 1
NL - Olanda 1
PH - Filippine 1
TR - Turchia 1
TW - Taiwan 1
Totale 25.711
Salva come PNG Salva come JPEG
Città #
Woodbridge 7.016
Wilmington 6.287
Houston 5.656
Ann Arbor 646
Fairfield 600
Chandler 445
Ashburn 358
Jacksonville 294
Seattle 282
Dublin 220
Cambridge 217
Medford 169
Dearborn 120
Beijing 114
New York 107
Rome 99
Zhengzhou 81
Lawrence 80
Singapore 58
Kraków 42
San Diego 35
Moscow 34
Menlo Park 32
Mülheim 30
Milan 23
Falls Church 21
Norwalk 18
Brno 16
Shanghai 16
Brussels 15
Hefei 15
Bologna 13
Kunming 13
London 13
Munich 13
Boardman 12
Helsinki 12
University Park 12
Los Angeles 11
Nanjing 11
Rieti 11
Hong Kong 10
Mountain View 10
San Mateo 10
Nürnberg 9
Palo Alto 9
Saint Petersburg 9
San Francisco 9
Redmond 8
Redwood City 8
Verona 8
Guangzhou 7
Nanchang 7
Creede 6
Hounslow 6
Auburn Hills 5
Chengdu 5
Santa Clara 5
Sassari 5
Acton 4
Changsha 4
Chongqing 4
Fuzhou 4
Hebei 4
Jinan 4
Shenyang 4
Toronto 4
Clifton 3
Colorado Springs 3
Detroit 3
Engelhard 3
Hangzhou 3
Hanoi 3
Indiana 3
Latina 3
Lima 3
Madrid 3
Pars 3
Phoenix 3
Seoul 3
São Paulo 3
Turin 3
Washington 3
Anzio 2
Baotou 2
Bellingham 2
Bussero 2
Canberra 2
Center 2
Chiswick 2
Council Bluffs 2
Donetsk 2
Duncan 2
Hanawada 2
Mexico 2
Minatomirai 2
Nauka 2
Nea Smyrni 2
Nuremberg 2
Porto Torres 2
Totale 23.517
Salva come PNG Salva come JPEG
Nome #
Persistent risk of HBV reactivation despite extensive lamivudine prophylaxis in haematopoietic stem cell transplant recipients who are anti-HBc-positive or HBV-negative recipients with an anti-HBc-positive donor 491
Treatment of acute graft-versus-host disease with prednisolone: significant survival advantage for day+5 responders and no advantage for nonresponders receiving anti-thymocyte globulin 481
Femoral catheters: safety and efficacy in peripheral blood stem cell collection 473
Possibility of long-term remission in patients with advanced hematologic malignancies after reduced intensity conditioning regimen (RIC) and allogeneic stem cell transplantation 451
Positive selection of CD34+ cells by immunoadsorption: factors affecting the final yield and hematopoietic recovery in patients with hematological malignancies and solid tumors 438
Bowel ultrasonography as an aid for diagnosis of intestinal acute graft-versus-host-disease after allogeneic haematopoietic stem cell transplantation 432
Autologous peripheral blood stem cell transplantation as first line treatment of multiple myeloma: an Italian multicenter study 428
Fibrin glue for refractory hemorrhagic cystitis after unrelated marrow, cord blood, and haploidentical hematopoietic stem cell transplantation 427
High incidence of post-transplant cytomegalovirus reactivations in myeloma patients undergoing autologous stem cell transplantation after treatment with bortezomib-based regimens: a survey from the Rome transplant network. 426
Aspergillus niger infection in patients with haematological diseases: a report of eight cases 420
Ceftriaxone plus amikacin in a single daily dose as empiric antibiotic therapy in granulocytopenic patients 420
Characterization of coagulase-negative staphylococcal isolates from blood with reduced susceptibility to glycopeptides and therapeutic options 417
Femoral catheters: safety and efficacy in peripheral blood stem cell collection 406
The therapeutic use of cord blood 405
Efficacy and safety of human leucocyte interferon-alpha treatment in patients younger than 60 years of age with polycythaemia vera 403
Localization of aspergillosis to the central nervous system among patients with acute leukemia: Report of 14 cases 397
A fatal case of invasive fungal sinusitis by Scopulariopsis acremonium in a bone marrow transplant recipient 396
Efficacy of caspofungin as secondary prophylaxis in patients undergoing allogeneic stem cell transplantation with prior pulmonary and/or systemic fungal infection 390
Management of carbapenem resistant Klebsiella pneumoniae infections in stem cell transplant recipients: An italian multidisciplinary consensus statement 390
Breakthrough fusariosis in a patient with acute lymphoblastic leukemia receiving voriconazole prophylaxis [6] 386
Sezary syndrome in relapse after reduced intensity allogeneic transplant successfully treated with donor lymphocyte infusion 386
Hepatitis B reactivation characterized by HBsAg negativity and anti-HbsAg antibodies persistence in haematopoietic stem cell transplanted patient after lamivudine withdrawal 384
aplastic anemia and viral hepatitis 383
The policy of the Rome Transplant Network (RTN), a metropolitan (2009). The Potential Application Of The Allogeneic Transplant By The Policy Of Widespread Donor Search: An Intention-To-Treat Analysis From The Rome Transplant Network. 383
Pre-transplant persistence of minimal residual disease does not contraindicate allogeneic stem cell transplantation for adult patients with acute myeloid leukemia 380
Haploidentical, unmanipulated,G-CSF primed bona marrow transplantation for patients with high risk hematological malignancies 378
Procalcitonin is a reliable marker of severe systemic infection in neutropenic haematological patients with mucositis 374
Pretransplant minimal residual disease level predicts clinical outcome in patients with acute myeloid leukemia receiving high-dose chemotherapy and autologous stem cell transplantation 372
Controversies on antibiotic lock technique duration: experience with a 3-day course for hematological patients 372
Platelet gel for treatment of mucocutaneous lesions related to graft-versus-host disease after allogeneic hematopoietic stem cell transplant. 370
Results of a multicenter, controlled, randomized clinical trial evaluating the combination of piperacillin/tazobactam and tigecycline in high-risk hematologic patients with cancer with febrile neutropenia. 370
Reduced intensity allogeneic transplantation in primary cutaneous t-cell lymphomas. 369
Femoral catheters: safety and efficacy in peripheral blood stem cell collection 368
Recombinant factor VIIa for the management of severe hemorrhages in patients with hematologic malignancies 368
3-Tesla MR spectroscopy in patients subjected to bone marrow transplantation: clinical correlations. 364
breakthrough fusariosis in a patient with acute lymphoblastic leukemia receiving voriconazole prophylaxis 364
Aplastica Anemia and Viral Hepatitis 363
A prospective study comparing quantitative Cytomegalovirus (CMV) polymerase chain reaction in plasma and pp65 360
Epidemiology of invasive fungal diseases in haematopoietic stem cell transplant recipients: preliminary analysis of a multicentre, prospective, observational study from Italy 360
The Rome Transplant Network model compared to the Italian Bone Marrow Donor Registry activity for unrelated donor search process and transplant efficiency for hematologic malignancy 359
Molecular remission in advanced acute promyelocytic leukaemia after treatment with the oral synthetic retinoid Tamibarotene 355
Total parenteral nutrition enriched with glutamine and ω-3 fatty acid in adult patients undergoing autologous stem cell transplantation. 353
Development of cellulitis caused by Aeromonas hydrophila in allogeneic hematopoietic transplantation: a case report. 348
Incidence and outcome of invasive fungal diseases after allogeneic stem cell transplantation: a prospective study of the Gruppo Italiano Trapianto Midollo Osseo (GITMO 348
Outcomes of allogeneic stem cell transplantation for secondary therapy-related acute myeloid leukaemia 348
Positive selection of CD34+ cells by immunoadsorption: factors affecting the final yield and hematopoietic recovery in patients with hematological malignancies and solid tumors 341
Peripheral polyneuropathy during treatment with alpha-2 interferon 339
Platelet gel is highly effective in treating muco-cutaneous lesions related to graft-versus-host disease 333
Extracorporeal photochemotherapy in the treatment of acute and chronic GvHD: experience from Rome Transplant Network 333
Bone marrow processing with a gravity sedimentation technique: experience of 13 cases 332
Reduced-intensity conditioning combined with standard GvHD prophylaxis is tolerable and highly effective for patients with primary cutaneous T-cell lymphomas undergoing allogeneic transplantation in advanced disease stage. 326
Successful treatment of disseminated fusariosis with high dose liposomal amphotericin-B in a patient with acute lymphoblastic leukemia [4] 320
Rituximab in post allogeneic hematopoietic stem cell transplantation membranous nephropathy: a case report. 319
Fibrin glue directly applied on damaged bladder mucosa during cystoscopy is highly effective to treat severe, refractory, haemorrhagic cystitis after allogeneic transplant 315
Allogeneic hematopoietic stem cell transplantation in Primary Cutaneous T Cell Lymphoma 310
Extracorporeal photopheresis as first-line treatment in high-risk graft-versus-host disease 309
Quality controls of cord blood units according to JACIE standards are highly predictive in unrelated cord blood transplant 309
Fibrin glue therapy for severe hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation 306
Il Trapianto di Cellule Stminali Emopoietiche. 300
Level of minimal residual disease after consolidation therapy predicts outcome in acute myeloid leukemia 297
Incidence, Risk Factors and Outcome of Pre-engraftment Gram-Negative Bacteremia after Allogeneic and Autologous Hematopoietic Stem Cell Transplantation: An Italian Prospective Multicenter Survey 283
Unmanipulated bone marrow transplantation from haplo-identical related donor for patients with high-risk haematological malignancies 275
Molecular remission in advanced acute promyelocytic leukaemia after treatment with the oral synthetic retinoid Tamibarotene 274
Epidemiological survey on severe infectious diseases 265
The potential application of the allogeneic transplant according to a widespread donor search policy: an intention-to-treat analysis from the Rome Transplant Network 257
The Potential Application of the Allogeneic Transplant by the Policy of Widespread Donor Search: an Intention- To-Treat Analysis from the Rome Transplant Network . 256
Gemtuzumab ozogamicin in combination with intensive chemotherapy for relapsed/refractory acute myeloid leukemia 237
Haploidentical, G-CSF-primed, unmanipulated bone marrow transplantation for patients with high-risk hematological malignancies: an update 159
A fatal case of invasive fungal sinusitis by Scopulariopsis acremonium in a bone marrow transplant recipient 137
MATCHED-PAIR ANALYSIS OF TRANSPLANT FROM HAPLOIDENTICAL, UNMANIPULATED BONE MARROW DONOR VERSUS HLA IDENTICAL SIBLING FOR PATIENTS WITH HEMATOLOGICAL MALIGNANCIES 136
Procalcitonin is a reliable marker of severe systemic infection in neutropenic haematological patients with mucositis 124
Preliminary results of a counselling programme for fertility preservation in female cancer patients: The experience of the GEMME DORMIENTI network 124
Sezary syndrome in relapse after reduced intensity allogeneic transplant successfully treated with donor lymphocyte infusion 123
Fibrin glue for refractory hemorrhagic cystitis after unrelated marrow, cord blood, and haploidentical hematopoietic stem cell transplantation 120
Haploidentical, unmanipulated, G-CSF-primed bone marrow transplantation for patients with high-risk hematologic malignancies 119
Infections by carbapenem-resistant Klebsiella pneumoniae in SCT recipients: a nationwide retrospective survey from Italy 117
High incidence of post-transplant cytomegalovirus reactivations in myeloma patients undergoing autologous stem cell transplantation after treatment with bortezomib-based regimens: a survey from the Rome transplant network 114
Platelet-rich plasma as treatment for persistent ocular epithelial defects 108
Cerebellar Neurocysticercosis as Long-Term Complication of Allogeneic Haematopoietic Stem Cell Transplantation from Haploidentical Donor 107
Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study 103
Identification of Predictive Factors for Overall Survival and Response during Hypomethylating Treatment in Very Elderly (≥75 Years) Acute Myeloid Leukemia Patients: A Multicenter Real-Life Experience 12
RISK-ADAPTED MRD-DIRECTED THERAPY FOR YOUNG ACUTE MYELOID LEUKEMIA ADULTS: 6-YEAR UPDATE OF THE GIMEMA AML1310 TRIAL 11
Totale 25.906
Salva come PNG Salva come JPEG
Categoria #
all - tutte 46.283
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 46.283
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20206.107 0 547 478 566 541 705 601 539 535 617 503 475
2020/20214.042 459 465 458 549 360 448 503 372 109 110 177 32
2021/2022803 27 105 43 47 26 74 39 45 48 59 48 242
2022/20231.122 118 108 48 161 77 241 85 62 122 13 64 23
2023/2024402 45 14 19 11 39 125 17 8 11 3 3 107
2024/2025109 83 26 0 0 0 0 0 0 0 0 0 0
Totale 25.906